PP2B-dependent NO production in the medullary thick ascending limb during diabetes

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 2, 2009, Pages

  Foster, Jan M ^a   Carmines, Pamela K ^b   Pollock, Jennifer S ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Calcineurin; Diabetes mellitus; Nitric oxide; Nitric oxide synthase; Protein phosphatase 2B

Indexed keywords

CALCINEURIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRITE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HENLE LOOP; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM BALANCE; STREPTOZOCIN DIABETES;

EID: 68049089958     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90760.2008     Document Type: Article

References (53)

1. Andoh TF, Bennet WM. Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens 7: 265-270, 1998.
2. Buttini M, Limonta S, Luyten M, Boddeke H. Distribution of calcineurin A isoenzyme mRNAs in rat thymus and kidney. Histochem J 27: 291-299, 1995.
3. Chamberlin ME, LeFurgey A, Mandel LJ. Suspension of medullary thick ascending limb tubules from the rabbit kidney. Am J Physiol Renal Fluid Electrolyte Physiol 247: F955-F964, 1984.
4. Clipstone NA, Crabtree GR. Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. Ann NY Acad Sci 696: 20-30, 1993.
5. Conde M, Andrade J, Bedoya FJ, Santa Maria C, Sobrino F. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Immunology 84: 476-481, 1995.
6. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25-28, 1997.
7. DiPetrillo K, Coutermarsh B, Gesek FA. Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol 284: F113-F121, 2003.
8. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284: R1-R12, 2003.
9. 2+/calmodulin- dependent endothelial nitric oxide synthase activity. Circ Res 88: 68-75, 2001.
10. Garcia NH, Stoos BA, Carretero OA, Garvin JL. Mechanism of the nitric oxide-induced blockade of collecting duct water permeability. Hypertension 27: 679-683, 1996.
11. Gooch JL, Barnes JL, Garcia S, Abboud HE. Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation. Am J Physiol Renal Physiol 284: F144-F154, 2003.
12. Gooch JL, Pablo PE, Guler RL, Abboud HE, Barnes JL. Differential expression of calcineurin A isoforms in the diabetic kidney. J Am Soc Nephrol 15: 1421-1429, 2004.
13. +-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest 95: 2083-2088, 1995.
14. Halloran PF, Kung L, Noujaim J. Calcineurin and the biological effect of cyclosporine and tacrolimus. Transplant Proc 30: 2167-2170, 1998.
15. Harris MD, Ju H, Venema VJ, Liang H, Zou R, Michell BJ, Chen ZP, Kemp BE, Venema RC. Reciprocal phosphorylation and regulation of endothelial nitric oxide synthase in response to bradykinin stimulation. J Biol Chem 276: 16587-16591, 2001.
16. Herrera M, Silva GB, Garvin JL. A high salt diet dissociates NO synthase-3 expression and NO production by the THAL. Hypertension 47: 95-101, 2006.
17. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Mü nzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14-E22, 2001.
18. Hortelano S, Castilla M, Torres A, Tejedor A, Bosca L. Potentiation by nitric oxide of cyclosporin A and FK506-induced apoptosis in renal proximal tubule cells. J Am Soc Nephrol 11: 2315-2323, 2000.
19. Hoshiyama M, Li B, Yao J, Harada T, Morioka T, Oite T. Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp Nephrol 95: 62-68, 2003.
20. Ju H, Zou R, Venema VJ, Venema RC. Direct interaction of endothelial nitric oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 272: 18522-18525, 1997.
21. Kosaka H, Yoneyama H, Zhang L, Fujii S, Yamamoto A, Igarashi J. Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine. FASEB J 17: 636-643, 2003.
22. Lee DL, Sasser JM, Hobbs JL, Boriskie A, Pollock DM, Carmines PK, Pollock JS. Posttranslational regulation of NO synthase activity in the renal medulla of diabetic rats. Am J Physiol Renal Physiol 288: F82-F90, 2005.
23. Li N, Yi FX, Spurrier JL, Bobrowitz CA, Zou AP. Production of superoxide through NAPH oxidase in thick ascending limb of Henle's loop in rat kidney. Am J Physiol Renal Physiol 282: F1111-F1119, 2002.
24. Li S, Seitz R, Lisanti MP. Phosphorylation of caveolin by Src tryosine kinases. The α-isoform of caveolin is selectively phosphorylated by vSrc in vivo. J Biol Chem 271: 3863-3868, 1996.
25. +-ATPase in opossum kidney cells. Kidney Int 56: 627-634, 1999.
26. Liu J, Albers MW, Wandless TJ, Luan S, Alberg DG, Belshaw PJ, Cohen P, MacKintosh C, Klee CB, Schreiber SL. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31: 3896-3901, 1992.
27. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815, 1991.
28. Marumo T, Nakaki T, Hishikawa K, Suzuki H, Kato R, Saruta T. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension 25: 764-768, 1995.
29. Mohaupt MG, Elzie JL, Ahn KY, Clapp WL, Wilcox CS, Kone BC. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int 46: 653-665, 1994.
30. Mori T, Cowley AW Jr. Renal oxidative stress in medullary thick ascending limbs produced by elevated NaCl and glucose. Hypertension 43: 341-346, 2004.
31. Morrissey J, McCracken R, Kaneto H, Vehaskari M, Montani D, Klahr S. Location of inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 45: 998-1005, 1994.
32. Norgaard K, Feldt-Rasmussen B. Sodium retention and insulin treatment in insulin-dependent diabetes mellitus. Acta Diabetol 31: 19-25, 1994.
33. Oberbäumer I, Moser D, Bachmann S. Nitric oxide synthase 1 mRNA: tissue-specific variants from rat with alternative first exons. Biol Chem 379: 913-919, 1998.
34. O'Keefe SJ, O'Neill EA. Cyclosporin A and FK-506: immunosuppression, inhibition of transcription and the role of calcineurin. Perspect Drug Disc Design 2: 85-102, 1994.
35. Ortiz PA, Hong NJ, Garvin JL. Luminal flow induces eNOS activation and translocation in the rat thick ascending limb. Am J Physiol Renal Physiol 287: F274-F280, 2004.
36. Park KM, Byun JY, Kramers C, Kim JI, Huang PL, Bonventre JV. Inducible nitric oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 278: 27256-27266, 2003.
37. Plato CF, Stoos BA, Wang D, Garvin JL. Endogenous nitric oxide inhibits chloride transport in the thick ascending limb. Am J Physiol Renal Physiol 276: F159-F163, 1999.
38. Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev 80: 1483-1521, 2000.
39. Sasser JM, Sullivan JC, Hobbs JL, Yamamoto T, Pollock DM, Carmines PK, Pollock JS. Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol 18: 143-154, 2007.
40. Sharma K, Danoff TM, DePiero A, Ziyadeh F. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. Biochem Biophys Res Commun 207: 80-88, 1995.
41. Shenolikar S. Protein phosphatase regulation by endogenous inhibitors. Semin Cancer Biol 6: 219-227, 1995.
42. Shin SJ, Lai FJ, Wen JD, Hsiao PJ, Hsieh MC, Tzeng TF, Chen HC, Guh JY, Tsai JH. Neuronal and endothelial nitric oxide synthase expression in outer medulla of streptozotocin-induced diabetic rat kidney. Diabetologia 43: 649-659, 2000.
43. Strojek K, Grzeszczak W, Lacka B, Gorska J, Keller CK, Ritz E. Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria. Diabetologia 38: 1443-1448, 1995.
44. Taler SJ, Textor SC, Canzanello VJ, Schwartz L. Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf 20: 437-449, 1999.
45. Terada H, Matsushita M, Lu YF, Shirai T, Li ST, Tomizawa K, Moriwaki A, Nishio S, Date I, Ohmoto T, Matsui H. Inhibition of excitatory neuronal cell death by cell-permeable calcineurin autoinhibitory peptide. J Neurochem 87: 1145-1151, 2003.
46. Widder JD, Chen W, Li L, Dikalov S, Thöny B, Hatakeyama K, Harrison DG. Regulation of tetrahydrobiopterin biosynthesis by shear stress. Circ Res 101: 830-838, 2007.
47. - cotransport activity in cultured mouse medullary thick ascending limb cells. Kidney Int 58: 1652-1663, 2000.
48. Wu MS, Yang CW, Bens M, Yu HM, Huang JY, Wu CH, Huang CC, Vandewalle A. Cyclosporin inhibits nitric oxide production in medullary thick ascending limb cultured cells. Nephrol Dial Transplant 13: 2814-2820, 1998.
49. 1) receptors in mouse medullary thick ascending limb cells. Nephrol Dial Transplant 18: 1458-1465, 2003.
50. Xu Y, Krukoff TL. Adrenomedullin stimulates nitric oxide production from primary rat hypothalamic neurons: roles of calcium and phosphatases. Mol Pharmacol 72: 112-120, 2007.
51. Zeidel ML, Silva P, Brenner BM, Seifter JL. cGMP mediates effects of atrial peptides on medullary collecting duct cells. Am J Physiol Renal Fluid Electrolyte Physiol 252: F551-F559, 1987.
52. Zhang Y, Brovkovych V, Brovkovych S, Tan F, Lee BS, Sharma T, Skidgel RA. Dynamic receptor-dependent activation of inducible nitric oxide synthase by ERK-mediated phosphorylation of Ser745. J Biol Chem 282: 32453-32461, 2007.
53. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension 37: 547-553, 2001.